Skip to content
The Department of Neurology has a long and dynamic legacy of promoting diversity and inclusion in the workplace and health care setting.
Contact our scheduling team to make an in-person or Virtual Visit appointment
Learn about our Adult Neurology and Child Neurology Residency Programs.
Clinical trials are a key component of the research mission of the Department of Neurology at CUIMC
Showing 81 - 90 of 125 results.
Researchers at Columbia University Irving Medical Center have developed eye drops that could prevent vision loss after retinal vein occlusion.
"In our experience, approximately every fifth patient that was hospitalized was admitted to the ICU and had some degree of disorders of consciousness,” said Dr. Jan Claassen.
Elkind serves as chief of the Division of Neurology Clinical Outcomes Research and Population Sciences in the Department of Neurology at CUIMC.
"It seems like people are afraid of getting the virus, or maybe they're afraid of adding to the burden on the doctors and the hospital," said Dr. Mitchell Elkind.
Researchers have converted a bacterial toxin into a genome editing tool that, for the first time, can make precise changes to DNA in mitochondria, the cell’s power plants.
Introducing clinicians and basic scientists who joined Columbia Neurology on July 1, 2020.
The Alzheimer’s epidemic no one is talking about. That’s where the work of Jennifer J. Manly, PhD, a professor of neuropsychology at Columbia University Irving Medical Center, comes in.
Congratulations to Drs. Cigdem Akman, Mitchell Elkind, Andrew Lassman, Randolph Marshall, Kirk Roberts, Wendy Vargas, and Joshua Willey.
Child Neurology Resident Dr. Angela Curcio recently conducted a JCN podcast interview with Pediatric Epileptologist Dr. Rana Said of UT Southwestern Medical Center.
A patient of Dr. Joshua Willey has shared her stroke story, in support of Dr. Willey’s efforts to help the public understand that avoiding hospitals for fear of COVID-19 could have dire consequences.